Mapping and Ablation of Ventricular Tachycardia in Nonischemic Left Ventricular Cardiomyopathy
Syed Rafay A Sabzwari1, Daniel W Groves2, Wendy S Tzou1
1Cardiac Electrophysiology Section, Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Insights
Nonischemic cardiomyopathy can cause ventricular arrhythmias due to substrate variations. This review covers mapping and ablation strategies, emphasizing multimodality imaging for improved patient outcomes in ventricular tachycardia.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
Background:
- Nonischemic cardiomyopathy encompasses diverse structural heart diseases, often with genetic origins.
- Many cases involve intramural or epicardial substrate predisposing to ventricular arrhythmias.
- Substrate distribution is etiology-dependent, impacting prognosis and ablation strategies.
Purpose of the Study:
- To review ventricular tachycardia (VT) mapping and ablation in nonischemic left ventricular cardiomyopathy (NILVC).
- To highlight current understanding of NILVC scar types and etiologies.
- To discuss the role of multimodality imaging and advanced ablation techniques.
Main Methods:
- Review of existing literature on VT mapping and ablation in NILVC.
- Analysis of substrate characteristics and their relationship to etiology.
- Evaluation of multimodality imaging's role in noninvasive mapping.
Main Results:
- Substrate distribution in NILVC is variable and linked to specific etiologies.
- Multimodality imaging aids in characterizing cardiomyopathy subtypes and guiding VT ablation.
- Adjunctive ablation techniques are crucial for managing complex substrates.
Conclusions:
- VT in NILVC presents unique challenges due to substrate heterogeneity.
- Multimodality imaging is invaluable for noninvasive substrate characterization and ablation guidance.
- Tailored ablation strategies are essential for effective VT management in this population.
Abstract:
Nonischemic cardiomyopathy incorporates a diverse group of structural heart disease, some of which are genetic in etiology, many of which involve intramural or epicardial substrate for ventricular arrhythmias. Substrate distribution varies according to etiology and has prognostic and procedural implications with regard to mapping and ablation. Multimodality imaging has played an important role in characterization of cardiomyopathy subtypes, as well as in guiding approach for ventricular tachycardia ablation in this challenging patient population. This review will summarize the available data on ventricular tachycardia mapping and ablation in patients with nonischemic left ventricular cardiomyopathy. Current understanding of nonischemic scar types, associated etiologies, as well as the value of multimodality imaging as an adjunctive, noninvasive mapping tool will be highlighted. Furthermore, adjunctive ablation techniques particularly for challenging substrate will be discussed.
More Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias